A buyer's guide for digital health teams: the reimbursement question to ask first, the channels that build a shortlist, and the ownership terms to insist on.
Why a generalist agency is the wrong fit for a digital health company
Most agencies learned their trade on local businesses. Their playbook is a map listing, a few 'near me' ads, and a review request after the visit. A digital health company has none of that. Nobody types 'remote patient monitoring near me.' Your buyer is a population-health director at a health system, a medical policy team inside a payer, or a benefits consultant advising a self-insured employer. They research quietly, build a shortlist from comparison pages and category directories, and only then ask for a demo. An agency that counts phone calls is counting the wrong thing.
The second gap is evidence and reimbursement. A prescription digital therapeutic often needs FDA clearance, through the 510(k) or De Novo pathway, before a payer will cover it. A remote patient monitoring program bills under specific remote-monitoring CPT codes. Your buyer wants that story on the first screen, next to your SOC 2 or HITRUST status. A generalist writes a homepage about features and buries the clearance in a footnote. That page gets forwarded to legal instead of turning into a signup.
The third gap is the math. Your funnel runs like any software company. A high-intent search becomes a demo. A demo becomes a signed program. A signed program becomes a renewing account once it reports its first outcome. The numbers that matter are the cost to land a signed program, the time to activation, and the payback period. A generalist reports sessions and form fills. Those figures cannot tell you whether a pilot cohort ever expanded to the full population, and that expansion is where the revenue lives.
The first question to ask: can they explain your reimbursement story back to you?
Before you talk budgets or channels, ask a candidate agency to describe, in their own words, how your product gets paid for. If you sell an RPM program, they should know it bills under monitoring CPT codes and that the buyer's finance team will check the math. If you sell a digital therapeutic, they should know whether your clearance came through 510(k) or De Novo, and that every marketing claim has to stay inside that indication. If they cannot do this on the first call, they will not be able to write the pages that get a compliance reviewer to say yes.
The same question reveals whether they understand your sales cycle. Health system and payer deals pass through procurement, a security questionnaire, and sometimes a formal RFP before a lead counts as pipeline. Ask how they would keep attribution alive across that gap. A good answer involves tagging every touch, syncing to your CRM, and reporting on signed programs rather than on the demo request from four months earlier. A vague answer means their reporting will stop at the top of the funnel.
One more test. Ask how they would handle a claim that your clinical team wants softened. The right agency treats your regulatory and clinical reviewers as part of the approval flow, not as a delay. They should expect a review round on every outcomes page. If they promise speed by skipping that step, end the call.
Where signed programs actually come from, in order
Start with organic comparison and reimbursement content, because that is where the shortlist gets built. A benefits consultant types 'population health management software' or 'cpt codes for remote patient monitoring' months before anyone books a call. An analyst at a health plan searches 'hitrust certified health data platform' or 'alternatives to' a competitor by name. If your pages answer those questions plainly, you are on the list before the RFP is drafted. Rankings take time, so this work should begin on day one.
Paid search comes next, aimed at category and competitor terms such as 'best remote patient monitoring platform' or 'fda cleared digital therapeutic.' LinkedIn campaigns can reach the exact titles on a buying committee, but only if the landing page answers a compliance reviewer's first three questions: clearance status, security attestation, and how the program gets reimbursed. Paid traffic sent to a feature page is money spent on a bounce.
AI search is now part of how a shortlist forms. When someone asks an assistant which care coordination platform suits an ACO managing readmissions, the answer draws on the same comparison content, directory listings, and customer quotes that feed regular search. Being named there is a result of the organic work, not a separate trick.
Lifecycle email closes the loop. A signed program that never reaches its first reported outcome does not renew. Onboarding built around that first outcome, nudges that move a pilot cohort toward full enrollment, and renewal messages timed to the buyer's budget cycle are the cheapest growth you have. Reviews still matter, but in this niche they look like outcomes case studies and directory listings a committee can cite.
Budget cycles, seasonality, and the cost question that matters
Demand here does not follow the weather. It follows money. Self-insured employers settle their benefits lineup ahead of open enrollment in the fall. Payers and health systems renew on fiscal-year calendars. A deal that misses a budget window can slide a full year. An agency that spreads your budget evenly across twelve months is ignoring the calendar your buyers live on. Ask how they would front-load content and paid reach before those windows open.
What is a customer worth? Not one demo. A signed program that enrolls a population, reports outcomes, and renews for years is worth many times the first contract, especially when a pilot grows from one cohort to the full eligible group. That is why cost per lead is a distraction. The question to ask is: 'What does it cost to land a signed program, and how many months until it pays back?' Follow it with: 'How will you show me which channel brings programs that renew and expand, and which brings programs that stall after the pilot?'
None of that can be answered without tracking in place from the start: demo and signup tracking tied to the campaign, a CRM sync, and a way to mark a program as activated when it reports its first outcome. If an agency cannot describe that setup, its reports will be traffic charts.
Red flags to watch for, and what you must own
The loudest red flag in health tech is a claim that outruns your evidence. If an agency drafts ad copy promising clinical results your studies do not support, or drifts outside your cleared indication, you carry the risk, not them. Second, watch how they handle data. Patient health information must never land in an ad pixel or a lead form field. In the US that is a HIPAA question. In Canada it falls under PIPEDA and provincial health privacy laws. An agency that shrugs at this is not ready for your category.
Then ask about ownership. Your domain, your website, your ad accounts, your analytics, your CRM data, and your directory listings should all sit under your company's name from the first day. Some agencies run ads from their own account, so history and audiences vanish when you leave. Some build sites on a platform you cannot export. Both are lock-in dressed up as convenience.
Last, read the reporting. If the dashboard shows sessions and marketing-qualified leads but never signed programs, activation, or payback, it is built to look busy rather than to prove value. Long fixed contracts send the same signal. A team that expects its results to keep you will offer month to month.
Six questions to ask every health tech marketing agency
Put every candidate through the same list and compare the answers side by side.
One: 'Explain how my product gets reimbursed and what that changes about the pages you would write.' Two: 'How will you keep attribution alive through procurement and a security review, and report on signed programs instead of demo requests?' Three: 'Where could patient data and marketing pixels meet in my funnel, and how do you keep them apart?' Four: 'How do you plan content and spend around open enrollment and fiscal-year renewals?' Five: 'Do I own the site, the ad accounts, the analytics, and the CRM data, and what happens the day we part ways?' Six: 'Show me how you would get my platform named when a buyer asks an AI assistant what to shortlist.'
The answers should be specific to your category, not recycled from a dental client. If you want a reference point on price, SearchPod publishes its rates in the open: Google Ads management at 10% of the ad budget with a $600 monthly minimum and no markup on spend, SEO at $50 per page starting at 10 pages, one-time website builds from $1,500 to $20,000+, $0 setup, month to month, and a 30-day guarantee where you do not pay if the first month does not work out. A free proposal comes back within one business day through /get-proposal. Treat those numbers as a benchmark for what open pricing looks like, then hold every agency, that one included, to the six questions above.
